Comparison Dexametason and Dexmedetomidine and combination Dexametason and ?Dexmedetomidine for nausea and vomiting after laparoscopy cholecystectomy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N100

Enrollment

164

Registered

2019-04-03

Start date

2019-02-04

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparascopy. Retained cholelithiasis following cholecystectomy

Interventions

Intervention 1: Intervention group 1: We inject 25 micro gram Dexmedetomidin (Hosperia Co) slowly before cutting surgery in Dexmedetomidine group. Intervention 2: Intervention group 2: We inject Dexam

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Laparoscopic candidate ASA class I and II No history of psychiatric and psychoeducational disorders No history of Parkinson's disease,motion sickness or no history of chemotherapy General anesthetic candidate 18 to 60 years Maximum surgical duration 150 minutes

Exclusion criteria

Exclusion criteria: Lack of conscientiousness

Design outcomes

Primary

Measure	Time frame
Nausea. Timepoint: Recovery and 2 and 4 hours after surgery. Method of measurement: Observation.;Vomiting. Timepoint: Recovery and 2 and 4 hours after surgery. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 68 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026